Western Regional Medical Center, Inc.

Goodyear, Arizona 85338

0 studies enrolling now · 16 studies all time

What they study most

Adenocarcinoma of the Cervix, Adenosquamous Cell Carcinoma of the Cervix, Breast Cancer, ER-positive Breast Cancer, Esophageal Cancer, Estrogen Receptor Positive Breast Cancer, Gastrointestinal Cancer Metastatic, HER-2 Positive Breast Cancer, HER2-positive Breast Cancer, Hilar Cholangiocarcinoma, Kidney Cancer Metastatic, Lung Cancer

Studies at this site

• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer — Completed
• A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) — Completed
• Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC — NO_LONGER_AVAILABLE
• Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal Cancer — Status unconfirmed
• Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) — Stopped early
• A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas — Stopped early
• Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer — Completed
• Interleukin-2 in Metastatic Melanoma — Stopped early
• 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer — Completed
• Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy — Stopped early
• Interleukin-2 in Metastatic Kidney Cancer — Stopped early
• Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer — Stopped early
• Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy — Stopped early
• Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma — Withdrawn before enrolling